QuantiaMD snags $10M for social networking site for doctors

23 hours ago Sep. 3, 2013 - 4:36 AM PDT

Quantia, an online community for doctors and the healthcare companies that want to market to them, has $10 million more in the bank. On Tuesday, the company said it had raised $7.5 million from Safeguard Scientifics in a $10 million Series B round. Currentinvestors, including Fuse Capital, contributed the remaining $2.5 million. The round follows $12 million raised in October and will be used for sales and marketing, the company said.

As doctors schedules become ever tighter, leaving less time for pharmaceutical sales reps and others peddling healthcare products and services, Quantia claims its site QuantiaMD gives doctors a place to engage with peers, while giving clients an effective environment for marketing. The service is free to doctors but charges other companies interested in building a presence on the site.

For doctors, a site like Quantia offers a private and secure place to tap the wisdom of peers and thats becoming increasingly attractive to physicians concerned about an uptick in government scrutiny surrounding digital health information. But its hardly the only site that offers peer-to-peer networking for medical professionals.

Doximity, a LinkedIn for doctors, provides physicians a free site for collaboration while earning revenue by charging clients who want to recruit doctors and find medical experts. And Sermo, which was acquired last year by health intelligence company WorldOne, also provides a peer forum for doctors while charging other companies to conduct online focus groups and surveys among its community. In addition to the funding, Quantia said it had surpassed 200,000 members, a benchmark similarly exceeded by Doximity last month.

Subscriber Content

Subscriber Content comes from GigaOM Pro, a revolutionary approach to market research without the high price tag. Visit any of our reports to subscribe.

Original post:
QuantiaMD snags $10M for social networking site for doctors

Related Posts

Comments are closed.